New York State Common Retirement Fund I Bio, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.23 - $0.46 $28,888 - $57,776	-125,600 Reduced 98.53%	1,874 $0
Q4 2021 Feb 02, 2022	SELL	$0.55 - $1.04 $151 - $287	-276 Reduced 0.22%	127,474 $70,000
Q3 2021 Nov 02, 2021	BUY	$1.06 - $1.52 $542 - $778	512 Added 0.4%	127,750 $135,000
Q2 2021 Aug 02, 2021	BUY	$1.22 - $1.65 $11,026 - $14,912	9,038 Added 7.65%	127,238 $192,000
Q1 2021 May 11, 2021	BUY	$1.18 - $2.62 $17,464 - $38,776	14,800 Added 14.31%	118,200 $182,000
Q4 2020 Feb 08, 2021	BUY	$1.05 - $2.24 $61,950 - $132,160	59,000 Added 132.88%	103,400 $109,000
Q3 2020 Nov 05, 2020	SELL	$1.7 - $6.41 $30,260 - $114,098	-17,800 Reduced 28.62%	44,400 $90,000
Q2 2020 Aug 07, 2020	BUY	$0.87 - $2.46 $54,114 - $153,012	62,200 New	62,200 $138,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.